
STAT+: What Medicare Advantage enrollment could look like for next year
You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow…

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow…
.jpg)
After his son Michael was diagnosed with a devastating, ultra-rare disease in 2019, Terry Pirovolakis…

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow…

The Biden administration on Monday announced it would finalize a highly anticipated proposal meant to…

Want to stay on top of health news? Sign up to get our Morning Rounds newsletter in…

If you twirl a bottle of alcohol and squint, you might see a text box…

LONDON — Patients in England with a rare blood disorder will now be able to…

Alcohol policy researchers are fuming over a letter sent by members of Congress last month,…

In President Biden’s address to the nation after dropping out of the election race, he…

The Biden administration isn’t doing enough to ensure people living in recovery housing have access…

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money…

You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow…

Want to stay on top of the science and politics driving biotech today? Sign up to get…
.jpg)
Want to stay on top of the science and politics driving biotech today? Sign up to get…

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Want to stay on top of the science and politics driving biotech today? Sign up to get…

The Food and Drug Administration’s power to make important regulatory decisions is in question after…
.jpg)
Want to stay on top of the science and politics driving biotech today? Sign up to get…

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Want to stay on top of the science and politics driving biotech today? Sign up to get…
.jpg)
Rise and shine, everyone, another hot day is on the way. The forecast – at…

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Just two weeks ago, it appeared Novant Health was on the precipice of finalizing a…

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Want to stay on top of the science and politics driving biotech today? Sign up to get…

The need-to-know this morning Biogen and Ionis Pharmaceuticals are ending their development of an experimental drug for ALS based on…

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Want to stay on top of the science and politics driving biotech today? Sign up to get…
.jpg)
Want to stay on top of the science and politics driving biotech today? Sign up to get…

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Want to stay on top of the science and politics driving biotech today? Sign up to get…

Want to stay on top of the science and politics driving biotech today? Sign up to get…

New biotech newsletter launching tomorrow. Don’t miss out. Good morning, everyone. Damian here with the…

New biotech newsletter launching this Thursday. Don’t miss out. Hello, everyone. Damian here with a look…

New biotech newsletter launching this Thursday. Don’t miss out. Hey there. Today, we discuss the…

Want to stay on top of the science and politics driving biotech today? Sign up to get…

The psychedelic ibogaine is unlikely to ever receive approval as a treatment for opioid addiction,…